» Articles » PMID: 33326751

Pulse-Chase Proteomics of the App Knockin Mouse Models of Alzheimer's Disease Reveals That Synaptic Dysfunction Originates in Presynaptic Terminals

Abstract

Compromised protein homeostasis underlies accumulation of plaques and tangles in Alzheimer's disease (AD). To observe protein turnover at early stages of amyloid beta (Aβ) proteotoxicity, we performed pulse-chase proteomics on mouse brains in three genetic models of AD that knock in alleles of amyloid precursor protein (APP) prior to the accumulation of plaques and during disease progression. At initial stages of Aβ accumulation, the turnover of proteins associated with presynaptic terminals is selectively impaired. Presynaptic proteins with impaired turnover, particularly synaptic vesicle (SV)-associated proteins, have elevated levels, misfold in both a plaque-dependent and -independent manner, and interact with APP and Aβ. Concurrent with elevated levels of SV-associated proteins, we found an enlargement of the SV pool as well as enhancement of presynaptic potentiation. Together, our findings reveal that the presynaptic terminal is particularly vulnerable and represents a critical site for manifestation of initial AD etiology. A record of this paper's transparent peer review process is included in the Supplemental Information.

Citing Articles

Systems-Level Interactome Mapping Reveals Actionable Protein Network Dysregulation Across the Alzheimer's Disease Spectrum.

Bay S, Rodina A, Haut F, Roychowdhury T, Argyrousi E, Staniszewski A Res Sq. 2025; .

PMID: 39989971 PMC: 11844643. DOI: 10.21203/rs.3.rs-5930673/v1.


Isotope Encoded Spatial Biology Identifies Amyloid Plaque-Age-Dependent Structural Maturation, Synaptic Loss, and Increased Toxicity.

Wood J, Wood J, Dulewicz M, Ge J, Stringer K, Szadziewska A Res Sq. 2025; .

PMID: 39975899 PMC: 11838767. DOI: 10.21203/rs.3.rs-5829037/v1.


Human and mouse proteomics reveals the shared pathways in Alzheimer's disease and delayed protein turnover in the amyloidome.

Yarbro J, Han X, Dasgupta A, Yang K, Liu D, Shrestha H Nat Commun. 2025; 16(1):1533.

PMID: 39934151 PMC: 11814087. DOI: 10.1038/s41467-025-56853-3.


Levetiracetam prevents Aβ production through SV2a-dependent modulation of App processing in Alzheimer's disease models.

Rao N, DeGulis O, Nomura T, Lee S, Hark T, Dynes J bioRxiv. 2024; .

PMID: 39554163 PMC: 11565754. DOI: 10.1101/2024.10.28.620698.


Human-mouse proteomics reveals the shared pathways in Alzheimer's disease and delayed protein turnover in the amyloidome.

Yarbro J, Han X, Dasgupta A, Yang K, Liu D, Shrestha H bioRxiv. 2024; .

PMID: 39484428 PMC: 11527136. DOI: 10.1101/2024.10.25.620263.


References
1.
Sheng M, Sabatini B, Sudhof T . Synapses and Alzheimer's disease. Cold Spring Harb Perspect Biol. 2012; 4(5). PMC: 3331702. DOI: 10.1101/cshperspect.a005777. View

2.
Chhangani D, Endo F, Amanullah A, Upadhyay A, Watanabe S, Mishra R . Mahogunin ring finger 1 confers cytoprotection against mutant SOD1 aggresomes and is defective in an ALS mouse model. Neurobiol Dis. 2015; 86:16-28. DOI: 10.1016/j.nbd.2015.11.017. View

3.
Tucker W, Weber T, Chapman E . Reconstitution of Ca2+-regulated membrane fusion by synaptotagmin and SNAREs. Science. 2004; 304(5669):435-8. DOI: 10.1126/science.1097196. View

4.
Fanutza T, Prete D, Ford M, Castillo P, DAdamio L . APP and APLP2 interact with the synaptic release machinery and facilitate transmitter release at hippocampal synapses. Elife. 2015; 4:e09743. PMC: 4755753. DOI: 10.7554/eLife.09743. View

5.
Kwart D, Gregg A, Scheckel C, Murphy E, Paquet D, Duffield M . A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ. Neuron. 2019; 104(5):1022. DOI: 10.1016/j.neuron.2019.11.010. View